NUP54 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.983800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.774170E-01
Normal-vs-Stage2
5.492000E-01
Normal-vs-Stage3
6.836200E-02
Normal-vs-Stage4
5.829400E-01
Stage1-vs-Stage2
4.338800E-01
Stage1-vs-Stage3
3.999800E-01
Stage1-vs-Stage4
1.063650E-01
Stage2-vs-Stage3
1.510030E-01
Stage2-vs-Stage4
1.129190E-01
Stage3-vs-Stage4
8.191800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.181200E-01
Normal-vs-AfricanAmerican
4.896400E-01
Normal-vs-Asian
3.590800E-01
Caucasian-vs-AfricanAmerican
9.978600E-01
Caucasian-vs-Asian
4.194000E-01
AfricanAmerican-vs-Asian
6.295600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.542600E-01
Normal-vs-Female
5.781800E-01
Male-vs-Female
2.970200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.420500E-02
Normal-vs-Age(41-60Yrs)
9.036200E-01
Normal-vs-Age(61-80Yrs)
3.512200E-01
Normal-vs-Age(81-100Yrs)
4.250400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.906190E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.827400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.790400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.236300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.336000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.745000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.950600E-01
Normal-vs-Daily Drinker
2.943800E-01
Normal-vs-Weekly Drinker
6.378200E-01
Normal-vs-Occasional Drinker
8.551800E-01
Normal-vs-Social Drinker
5.192400E-01
Non Drinker-vs-Daily Drinker
6.449800E-01
Non Drinker-vs-Weekly Drinker
7.745600E-01
Non Drinker-vs-Occasional Drinker
1.722830E-01
Non Drinker-vs-Social Drinker
6.702400E-01
Daily Drinker-vs-Weekly Drinker
5.557600E-01
Daily Drinker-vs-Occasional Drinker
9.072100E-02
Daily Drinker-vs-Social Drinker
4.254600E-01
Weekly Drinker-vs-Occasional Drinker
4.753800E-01
Weekly Drinker-vs-Social Drinker
9.519600E-01
Occasional Drinker-vs-Social Drinker
4.143200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.790200E-01
Normal-vs-Grade 2
8.464200E-01
Normal-vs-Grade 3
7.898800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.642700E-03
Grade 1-vs-Grade 3
1.496010E-03
Grade 1-vs-Grade 4
9.790200E-01
Grade 2-vs-Grade 3
1.446790E-01
Grade 2-vs-Grade 4
8.464200E-01
Grade 3-vs-Grade 4
7.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.118200E-01
Normal-vs-NonDiabetic
4.816600E-01
Diabetic-vs-NonDiabetic
2.902800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.749800E-01
Normal-vs-NoPancreatitis
4.515000E-01
Pancreatitis-vs-NoPancreatitis
6.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.272200E-01
Normal-vs-N1
5.640800E-01
N0-vs-N1
5.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.605800E-01
Normal-vs-TP53-NonMutant
4.567600E-01
TP53-Mutant-vs-TP53-NonMutant
1.798170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
